{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:11:26Z","timestamp":1767895886839,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clindermatol.2025.02.010","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T14:25:03Z","timestamp":1740061503000},"page":"900-905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethics of reversible dermatologic care in transgender and gender-diverse adolescents under restrictive and ambiguous laws"],"prefix":"10.1016","volume":"43","author":[{"given":"Priya Patel","family":"Housley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami K.","family":"Saikaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2025.02.010_bib0001","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). Available at: https:\/\/www.psychiatry.org\/psychiatrists\/practice\/dsm. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-clinpsy-072220-020326","article-title":"Mental health of transgender and gender diverse youth","volume":"19","author":"Wittlin","year":"2023","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0003","doi-asserted-by":"crossref","first-page":"NP123","DOI":"10.1093\/asj\/sjy253","article-title":"Nonsurgical management of facial masculinization and feminization","volume":"39","author":"Ascha","year":"2019","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0004","unstructured":"Movement Advancement Project. Bans on best practice medical care for transgender youth. Available at: http:\/\/www.mapresearch.org\/equality-maps\/healthcare_youth_medical_care_bans. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0005","unstructured":"Alabama Legislature. Alabama Vulnerable Child Compassion and Protection Act. SB184, 2022 Reg. Sess. (Ala. 2022). Available at: https:\/\/www.billtrack50.com\/billdetail\/1446900#:~:text=This%20bill%2C%20known%20as%20the,certain%20medical%20conditions%20related%20to. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0006","unstructured":"Arizona Legislature. Prohibition on Irreversible Gender Reassignment Surgery. SB1138, 55th Leg., 2nd Reg. Sess. (Ariz. 2022). Available at: https:\/\/www.azleg.gov\/legtext\/55leg\/2r\/bills\/sb1138p.htm. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0007","unstructured":"Arkansas General Assembly. Arkansas Save Adolescents from Experimentation (SAFE) Act. HB1570, 93rd Gen. Assemb., Reg. Sess. (Ark. 2021). Available at: https:\/\/arkleg.state.ar.us\/Bills\/Detail?id=HB1570&ddBienniumSession=2021%2F2021R. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0008","unstructured":"Florida Board of Medicine. Standards of practice for the treatment of gender dysphoria in minors. Fla. Admin. Code Ann. r. 64B8-9.019 (2023). Available at: https:\/\/www.flrules.org\/gateway\/ruleNo.asp?id=64B8-9.019. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0009","unstructured":"Georgia General Assembly. Youth Health Protection Act. SB140, 2023 Reg. Sess. (Ga. 2023). Available at: https:\/\/legiscan.com\/GA\/bill\/SB140\/2023. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0010","unstructured":"Idaho Legislature. Vulnerable Child Protection Act. HB71, 67th Leg., 1st Reg. Sess. (Idaho 2023). Available at: https:\/\/legislature.idaho.gov\/wp-content\/uploads\/sessioninfo\/2023\/legislation\/H0071E1.pdf. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0011","unstructured":"Iowa General Assembly. Gender transition procedure-related activities for minors. HF623, 90th Gen. Assemb. (Iowa 2023). Available at: https:\/\/www.legis.iowa.gov\/docs\/publications\/LGi\/90\/HF623.pdf. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0012","unstructured":"Kentucky General Assembly. An act relating to children. SB150, 2023 Reg. Sess. (Ky. 2023). Available at: https:\/\/apps.legislature.ky.gov\/record\/23rs\/sb150.html. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0013","unstructured":"Louisiana State Legislature. Stop Harming Our Kids Act. HB648, 2023 Reg. Sess. (La. 2023). Available at: https:\/\/legiscan.com\/LA\/bill\/HB648\/2023. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0014","unstructured":"Mississippi Legislature. Regulate Experimental Adolescent Procedures (REAP) Act. HB1125, 2023 Reg. Sess. (Miss. 2023). Available at: https:\/\/billstatus.ls.state.ms.us\/documents\/2023\/html\/HB\/1100-1199\/HB1125IN.htm. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0015","unstructured":"Montana Legislature. Youth Health Protection Act. SB99, 68th Leg., 2023 Reg. Sess. (Mont. 2023). Available at: https:\/\/archive.legmt.gov\/bills\/2023\/billpdf\/SB0099.pdf. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0016","unstructured":"Nebraska Legislature. Let Them Grow Act. LB574, 108th Leg., 1st Sess. (Neb. 2023). Available at: https:\/\/nebraskalegislature.gov\/bills\/view_bill.php?DocumentID=49961. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0017","unstructured":"North Dakota Legislative Assembly. House Bill No. 1254. 68th Legislative assembly; 2023. Available at: https:\/\/www.legis.nd.gov. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0018","unstructured":"Ohio General Assembly. Sub. HB68: Saving Ohio Adolescents from Experimentation (SAFE) Act. 135th General assembly; 2023. Available at: https:\/\/www.legislature.ohio.gov. Accessed January 12, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0019","unstructured":"South Carolina General Assembly. HB4624: gender reassignment procedures. 125th General assembly; 2024. Available at: https:\/\/www.scstatehouse.gov. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0020","unstructured":"South Dakota Legislature. House Bill 1080: prohibit certain medical and surgical interventions on minor patients. 98th Legislative session; 2023. Available at: https:\/\/sdlegislature.gov. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0021","unstructured":"Tennessee General Assembly. Public chapter no. 1, SB1\/HB1. 113th General assembly; 2023. Available at: https:\/\/www.capitol.tn.gov. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0022","unstructured":"Texas Legislature. SB14: gender transitioning and gender reassignment procedures and treatments for certain children. 88th Legislature; 2023. Available at: https:\/\/capitol.texas.gov. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0023","unstructured":"Utah State Legislature. SB16: transgender medical treatments and procedures amendments. General session; 2023. Available at: https:\/\/le.utah.gov. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0024","unstructured":"West Virginia Legislature. HB2007: prohibiting certain medical practices. Regular session; 2023. Available at: https:\/\/www.wvlegislature.gov. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0025","unstructured":"Wyoming Legislature. Senate file 144: Chloe's Law. 67th Legislature, 2023 General session (Wyo. 2023). Available at: https:\/\/wyoleg.gov\/Legislation\/2023\/SF0144. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0026","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2015.10.013","article-title":"A potential role for the dermatologist in the physical transformation of transgender people: a survey of attitudes and practices within the transgender community","volume":"74","author":"Ginsberg","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0027","series-title":"The Growth of Logical Thinking from Childhood to Adolescence: An Essay on the Construction of Formal Operational Structures","author":"Inhelder","year":"1958"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0028","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jaad.2017.12.052","article-title":"The ethics of performing noninvasive, reversible gender-affirming procedures on transgender adolescents","volume":"79","author":"Waldman","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0029","unstructured":"US Food and Drug Administration. Dermal filler do's and don'ts for wrinkles, lips and more. Available at: https:\/\/www.fda.gov\/consumers\/consumer-updates\/dermal-filler-dos-and-donts-wrinkles-lips-and-more. Accessed January 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jacbts.2022.12.011","article-title":"Off-label use vs off-label marketing of drugs. Part 1: off-label use\u2014patient harms and prescriber responsibilities","volume":"8","author":"Van Norman","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0031","first-page":"22","article-title":"Nonmedical-grade injections of permanent fillers: medical and medicolegal considerations","volume":"6","author":"Styperek","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0032","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bodyim.2016.04.002","article-title":"A network analysis of body satisfaction of people with gender dysphoria","volume":"17","author":"van de Grift","year":"2016","journal-title":"Body Image"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0033","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsxm.2019.10.008","article-title":"Hormonal treatment effect on sexual distress in transgender persons: 2-year follow-up data","volume":"17","author":"Ristori","year":"2020","journal-title":"J Sex Med"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0034","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/abn0000399","article-title":"Social anxiety among transgender and gender nonconforming individuals: the role of gender-affirming medical interventions","volume":"128","author":"Butler","year":"2019","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0035","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1210\/jc.2016-1276","article-title":"Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data","volume":"101","author":"Fisher","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2025.02.010_bib0036","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1530\/eje.1.02231","article-title":"Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects","volume":"155","author":"Delemarre-van De Waal","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.725269","article-title":"Case report: successful use of minoxidil to promote facial hair growth in an adolescent transgender male","volume":"12","author":"Pang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0038","article-title":"Physical and psychological effects of gender-affirming hormonal treatment using intramuscular testosterone enanthate in Japanese transgender men","volume":"9","author":"Kirisawa","year":"2021","journal-title":"Sex Med"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0039","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jsxm.2019.06.014","article-title":"Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria","volume":"16","author":"Stoffers","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1507\/endocrj.EJ12-0319","article-title":"Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder","volume":"60","author":"Nakamura","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0041","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/1346-8138.13312","article-title":"Efficacy and safety of minoxidil 3% lotion for beard enhancement: a randomized, double-masked, placebo-controlled study","volume":"43","author":"Ingprasert","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0042","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1007\/s40618-024-02373-8","article-title":"Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy","volume":"47","author":"Marinelli","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0043","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2133.1998.02511.x","article-title":"Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis","volume":"139","author":"Gupta","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0044","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1471-6712.2007.00547.x","article-title":"Experiences of appearance-related teasing and bullying in skin diseases and their psychological sequelae: results of a qualitative study","volume":"22","author":"Magin","year":"2008","journal-title":"Scand J Caring Sci"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1751-0759-5-11","article-title":"Psychosocial judgements and perceptions of adolescents with acne vulgaris: a blinded, controlled comparison of adult and peer evaluations","volume":"5","author":"Ritvo","year":"2011","journal-title":"Biopsychosoc Med"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0046","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1440-1754.2006.00979.x","article-title":"Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students","volume":"42","author":"Purvis","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0047","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1038\/s41598-020-62715-3","article-title":"Systematic review of the epidemiology of acne vulgaris","volume":"10","author":"Heng","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0048","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jaad.2017.06.004","article-title":"Acne, sexual orientation, and mental health among young adults in the United States: a population-based, cross-sectional study","volume":"77","author":"Gao","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0049","first-page":"43","article-title":"Acne vulgaris in skin of color: a systematic review of the effectiveness and tolerability of current treatments","volume":"15","author":"Pathmarajah","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamadermatol.2020.5347","article-title":"Incidence and factors associated with acne among transgender patients receiving masculinizing hormone therapy","volume":"157","author":"Thoreson","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0051","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/pde.15113","article-title":"Management of acne in transgender and gender diverse youth part 1: gender affirming care and risk factors for the development of acne","volume":"39","author":"Boos","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0052","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/pde.15114","article-title":"Management of acne in transgender and gender diverse youth part 2: unique considerations and strategies in medical treatment","volume":"39","author":"Hollingshead","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0053","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/j.1939-4640.1997.tb02434.x","article-title":"5alpha-reductase inhibitors","volume":"18","author":"Rittmaster","year":"1997","journal-title":"J Androl"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0054","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/ced.13184","article-title":"Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients","volume":"42","author":"Moreno-Arrones","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.02.010_bib0055","unstructured":"UCSF Transgender Care. Overview of feminizing hormone therapy | gender affirming health program. Available at: https:\/\/transcare.ucsf.edu\/guidelines\/feminizing-hormone-therapy. Accessed January 14, 2025."}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:30:01Z","timestamp":1767879001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X25000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0738081X25000458"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.02.010","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethics of reversible dermatologic care in transgender and gender-diverse adolescents under restrictive and ambiguous laws","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}